Vivos therapeutics reports fourth quarter and full year 2022 financial results and provides operational update

2022 and early 2023 accomplishments, including capital raise, cost reductions and new technology acquisition, set the stage for potential 2023 revenue growth

VVOS Ratings Summary

VVOS Quant Ranking